# Faeth Therapeutics, Inc.: Form SC 13D/A, filed Nov 2, 2022

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: SC 13D/A
- Filed: 2022-11-02
- Accepted by EDGAR: Nov 2, 2022, 11:58 ET
- Period: not reported
- Accession: 0000921895-22-002887
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000092189522002887/sc13da113506002_11012022.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000092189522002887/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000092189522002887/sc13da113506002_11012022.htm

Filed Nov 2, 2022.
Source: SEC EDGAR, the filing index for accession 0000921895-22-002887. Last ingested by Listed: Nov 3, 2026, 23:17 ET. No prices; not investment advice.